JP2020511506A5 - - Google Patents

Download PDF

Info

Publication number
JP2020511506A5
JP2020511506A5 JP2019551998A JP2019551998A JP2020511506A5 JP 2020511506 A5 JP2020511506 A5 JP 2020511506A5 JP 2019551998 A JP2019551998 A JP 2019551998A JP 2019551998 A JP2019551998 A JP 2019551998A JP 2020511506 A5 JP2020511506 A5 JP 2020511506A5
Authority
JP
Japan
Prior art keywords
ethyl
pyrrole
hexahydropyrrolo
diethyl
dihydrofuran
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019551998A
Other languages
English (en)
Japanese (ja)
Other versions
JP7365237B2 (ja
JP2020511506A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/022574 external-priority patent/WO2018175188A1/en
Publication of JP2020511506A publication Critical patent/JP2020511506A/ja
Publication of JP2020511506A5 publication Critical patent/JP2020511506A5/ja
Priority to JP2023174368A priority Critical patent/JP7781122B2/ja
Application granted granted Critical
Publication of JP7365237B2 publication Critical patent/JP7365237B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019551998A 2017-03-21 2018-03-15 シグマ-2受容体の新規調節物質およびその使用方法 Active JP7365237B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023174368A JP7781122B2 (ja) 2017-03-21 2023-10-06 シグマ-2受容体の新規調節物質およびその使用方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762474277P 2017-03-21 2017-03-21
US62/474,277 2017-03-21
PCT/US2018/022574 WO2018175188A1 (en) 2017-03-21 2018-03-15 Novel modulators of the sigma-2 receptor and their method of use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023174368A Division JP7781122B2 (ja) 2017-03-21 2023-10-06 シグマ-2受容体の新規調節物質およびその使用方法

Publications (3)

Publication Number Publication Date
JP2020511506A JP2020511506A (ja) 2020-04-16
JP2020511506A5 true JP2020511506A5 (cg-RX-API-DMAC7.html) 2021-04-22
JP7365237B2 JP7365237B2 (ja) 2023-10-19

Family

ID=63585700

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019551998A Active JP7365237B2 (ja) 2017-03-21 2018-03-15 シグマ-2受容体の新規調節物質およびその使用方法
JP2023174368A Active JP7781122B2 (ja) 2017-03-21 2023-10-06 シグマ-2受容体の新規調節物質およびその使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023174368A Active JP7781122B2 (ja) 2017-03-21 2023-10-06 シグマ-2受容体の新規調節物質およびその使用方法

Country Status (5)

Country Link
US (3) US10961249B2 (cg-RX-API-DMAC7.html)
EP (1) EP3600290B1 (cg-RX-API-DMAC7.html)
JP (2) JP7365237B2 (cg-RX-API-DMAC7.html)
MA (1) MA49019A (cg-RX-API-DMAC7.html)
WO (1) WO2018175188A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9802924B2 (en) 2013-03-11 2017-10-31 Temple University Of The Commonwealth System Of Higher Education 5-hydroxytryptamine receptor 7 activity modulators and their method of use
EP3200589B1 (en) 2014-09-10 2026-03-11 Temple University Of The Commonwealth System Of Higher Education Novel 5-hydroxytryptamine receptor 7 activity modulators and their method of use
US10858368B2 (en) 2016-11-15 2020-12-08 Temple University—Of the Commonwealth System of Higher Education Modulators of the 5-hydroxytryptamine receptor 7 and their method of use
JP7365237B2 (ja) * 2017-03-21 2023-10-19 テンプル・ユニバーシティ-オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション シグマ-2受容体の新規調節物質およびその使用方法
EP3600289A4 (en) 2017-03-21 2020-08-05 Temple University - Of The Commonwealth System of Higher Education 5-HYDROXYTRYPTAMINE RECEPTOR 7 MODULATORS AND THE USE OF THESE AS THERAPEUTIC AGENTS
WO2019217890A1 (en) * 2018-05-11 2019-11-14 Temple University-Of The Commonwealth System Of Higher Education Novel functionalized lactams as modulators of the 5-hydroxytryptamine receptor 7 and their method of use
GB201809295D0 (en) 2018-06-06 2018-07-25 Institute Of Cancer Res Royal Cancer Hospital Lox inhibitors
CN112010859B (zh) * 2019-05-30 2022-07-19 中国科学院上海药物研究所 一种并环化合物、其制备方法和用途
AU2023323878A1 (en) * 2022-08-11 2025-01-30 Remynd N.V. (aza)spiroheptane derivatives for the treatment of neurodegenerative disorders

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005219438B2 (en) * 2004-03-03 2011-02-17 Chemocentryx, Inc. Bicyclic and bridged nitrogen heterocycles
GB0419192D0 (en) * 2004-08-27 2004-09-29 Merck Sharp & Dohme Therapeutic agents
JP2010509402A (ja) * 2006-11-13 2010-03-25 キング・ファーマシューティカルズ・リサーチ・アンド・デベロプメント・インコーポレイティッド A1アデノシン受容体のアロステリック調節剤
US8148408B2 (en) * 2008-05-09 2012-04-03 Abbott Laboratories Selective substituted pyridine ligands for neuronal nicotinic receptors
US8697888B2 (en) * 2012-01-06 2014-04-15 Vanderbilt University Substituted (1-(methylsulfonyl)azetidin-3-yl)(heterocycloalkyl)methanone analogs as antagonists of muscarinic acetylcholine M1 receptors
WO2014085413A1 (en) 2012-11-28 2014-06-05 Temple University - Of The Commonwealth System Of Higher Education Disubstituted oxazolidin-2-ones 5-hydroxytryptamine receptor 2b activity modulators
EP2928474B1 (en) 2012-12-07 2018-11-14 ChemoCentryx, Inc. Diazole lactams
US9802924B2 (en) 2013-03-11 2017-10-31 Temple University Of The Commonwealth System Of Higher Education 5-hydroxytryptamine receptor 7 activity modulators and their method of use
US9809545B2 (en) * 2013-03-27 2017-11-07 Merck Sharp & Dohme Corp. Factor XIa inhibitors
KR20160098506A (ko) * 2013-12-20 2016-08-18 라보라토리오스 델 드라. 에스테브.에스.에이. 통증에 대한 다양한 활성을 갖는 피페라진 유도체
EP3200589B1 (en) 2014-09-10 2026-03-11 Temple University Of The Commonwealth System Of Higher Education Novel 5-hydroxytryptamine receptor 7 activity modulators and their method of use
CR20170118A (es) * 2014-10-08 2017-07-10 Hoffmann La Roche Derivados espirodiamina como inhibidores de la aldosterona sintasa
TWI698436B (zh) * 2014-12-30 2020-07-11 美商佛瑪治療公司 作為泛素特異性蛋白酶7抑制劑之吡咯并及吡唑并嘧啶
US20180221365A1 (en) * 2015-05-12 2018-08-09 Temple University-Of The Commonwealth System Of Higher Education Novel sigma-2 receptor binders and their method of use
US10858368B2 (en) * 2016-11-15 2020-12-08 Temple University—Of the Commonwealth System of Higher Education Modulators of the 5-hydroxytryptamine receptor 7 and their method of use
EP3600289A4 (en) 2017-03-21 2020-08-05 Temple University - Of The Commonwealth System of Higher Education 5-HYDROXYTRYPTAMINE RECEPTOR 7 MODULATORS AND THE USE OF THESE AS THERAPEUTIC AGENTS
JP7365237B2 (ja) 2017-03-21 2023-10-19 テンプル・ユニバーシティ-オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション シグマ-2受容体の新規調節物質およびその使用方法
WO2019217890A1 (en) 2018-05-11 2019-11-14 Temple University-Of The Commonwealth System Of Higher Education Novel functionalized lactams as modulators of the 5-hydroxytryptamine receptor 7 and their method of use
CN115003675A (zh) 2019-11-13 2022-09-02 英联邦高等教育系统坦普尔大学 作为5-羟色胺受体7调节剂的新型官能化内酰胺及其使用方法
MX2022005819A (es) 2019-11-13 2022-08-16 Univ Temple Nuevas lactonas funcionalizadas como moduladores del receptor 7 de 5-hidroxitriptamina y su método de uso.

Similar Documents

Publication Publication Date Title
JP2020511515A5 (cg-RX-API-DMAC7.html)
JP6982376B2 (ja) Rorガンマ調節物質としての置換型テトラヒドロキノリン化合物
KR101958501B1 (ko) 설폭시민기 함유 4-아릴-n-페닐-1,3,5-트리아진-2-아민
JP6026427B2 (ja) 置換6,6−縮合窒素複素環化合物及びその使用
CN113365988A (zh) Shp2抑制剂及其应用
CN110294741B (zh) 用于制备抗癌剂al3818、其结晶形式和其盐的方法
JP6487925B2 (ja) セリン/トレオニンキナーゼ阻害剤
JP5656874B2 (ja) Pde9阻害剤として使用されるアミノヘテロ環化合物
TWI839363B (zh) 嘧啶化合物及包括其之供預防或治療癌症的藥學組成物
CA2749209C (en) Indole derivatives as anticancer agents
WO2014078813A1 (en) Compounds and compositions for the treatment of parasitic diseases
UA71535C2 (en) Corticotropine-releasing antagonists factor, methods for the preparation thereof, pharmaceuitical composition and a method for the treatment
CN103476759B (zh) 取代的4-芳基-n-苯基-1,3,5-三嗪-2-胺
JP2007523152A5 (cg-RX-API-DMAC7.html)
EP2032538A2 (en) Quinoline compounds and methods of use
JP2016522231A5 (cg-RX-API-DMAC7.html)
RU2017130825A (ru) Гетероциклическое соединение и содержащая его фармацевтическая композиция
KR20150119370A (ko) Cns 장애 및 다른 장애의 치료를 위한 pde4 동종효소의 억제제로서의 아자벤즈이미다졸 화합물
WO2013028590A1 (en) Pyrimidine pde10 inhibitors
JP6263194B2 (ja) スルホキシイミン基を含んでいるn−(ピリジン−2−イル)ピリミジン−4−アミン誘導体
JPWO2016006706A1 (ja) テトラヒドロピラニルメチル基を有するピリドン誘導体
JP2020503302A5 (cg-RX-API-DMAC7.html)
CN105283453B (zh) 含砜基的n-(吡啶-2-基)嘧啶-4-胺衍生物
JP2019537592A5 (cg-RX-API-DMAC7.html)
TW201605798A (zh) 新穎6-炔基吡啶